Amylin modulates the mesolimbic dopamine system to control energy balance

Neuropsychopharmacology

Volumn 40, Issue 2, 2015, Pages 372-385

  Mietlicki Baase, Elizabeth G ^a   Reiner, David J ^a   Cone, Jackson J ^b   Olivos, Diana R ^a   McGrath, Lauren E ^a   Zimmer, Derek J ^a   Roitman, Mitchell F ^b   Hayes, Matthew R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLIN; AMYLIN RECEPTOR; AMYLIN RECEPTOR AGONIST; ANOREXIGENIC AGENT; CALCITONIN RECEPTOR; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; MESSENGER RNA;

AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; EATING; GENETICS; LIPID DIET; MALE; METABOLISM; NERVE CELL; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VENTRAL TEGMENTUM; WEIGHT GAIN;

AMYLIN RECEPTOR AGONISTS; ANIMALS; APPETITE DEPRESSANTS; DIET, HIGH-FAT; DOPAMINE; EATING; ISLET AMYLOID POLYPEPTIDE; MALE; NEURONS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITONIN; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, ISLET AMYLOID POLYPEPTIDE; RNA, MESSENGER; VENTRAL TEGMENTAL AREA; WEIGHT GAIN;

EID: 84928700356     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.180     Document Type: Article

References (70)

1. Andrews PL, Horn CC (2006). Signals for nausea and emesis: implications for models of upper gastrointestinal diseases. Auton Neurosci 125: 100-115.
2. Baik JH (2013). Dopamine signaling in reward-related behaviors. Front Neural Circuits 7: 152.
3. Baldo BA, Kelley AE (2007). Discrete neurochemical coding of distinguishable motivational processes: insights from nucleus accumbens control of feeding. Psychopharmacology (Berl) 191: 439-459.
4. Banks WA, Kastin AJ (1998). Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin. Peptides 19: 883-889.
5. Banks WA, Kastin AJ, Maness LM, Huang W, Jaspan JB (1995). Permeability of the blood-brain barrier to amylin. Life Sci 57: 1993-2001.
6. Bassareo V, Di Chiara G (1999). Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments. Neuroscience 89: 637-641.
7. Bello NT, Kemm MH, Moran TH (2008). Salmon calcitonin reduces food intake through changes in meal sizes in male rhesus monkeys. Am J Physiol Regul Integr Comp Physiol 295: R76-R81.
8. Bence KK, Delibegovic M, Xue B, Gorgun CZ, Hotamisligil GS, Neel BG et al (2006). Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med 12: 917-924.
9. Berger B, Thierry AM, Tassin JP, Moyne MA (1976). Dopaminergic innervation of the rat prefrontal cortex: a fluorescence histochemical study. Brain Res 106: 133-145.
10. Beyene M, Carelli RM, Wightman RM (2010). Cue-evoked dopamine release in the nucleus accumbens shell tracks reinforcer magnitude during intracranial self-stimulation. Neuroscience 169: 1682-1688.
11. Brown HD, McCutcheon JE, Cone JJ, Ragozzino ME, Roitman MF (2011). Primary food reward and reward-predictive stimuli evoke different patterns of phasic dopamine signaling throughout the striatum. Eur J Neurosci 34: 1997-2006.
12. Chapman I, Parker B, Doran S, Feinle-Bisset C, Wishart J, Strobel S et al (2005). Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes. Diabetologia 48: 838-848.
13. Christopoulos G, Paxinos G, Huang XF, Beaumont K, Toga AW, Sexton PM (1995). Comparative distribution of receptors for amylin and the related peptides calcitonin gene related peptide and calcitonin in rat and monkey brain. Can J Physiol Pharmacol 73: 1037-1041.
14. Christopoulos G, Perry KJ, Morfis M, Tilakaratne N, Gao Y, Fraser NJ et al (1999). Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 56: 235-242.
15. Cone JJ, Chartoff EH, Potter DN, Ebner SR, Roitman MF (2013). Prolonged high fat diet reduces dopamine reuptake without altering DAT gene expression. PLoS One 8: e58251.
16. Cone JJ, McCutcheon JE, Roitman MF (2014). Ghrelin acts as an interface between physiological state and phasic dopamine signaling. J Neurosci 34: 4905-4913.
17. Dacquin R, Davey RA, Laplace C, Levasseur R, Morris HA, Goldring SR et al (2004). Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo. J Cell Biol 164: 509-514.
18. Dobi A, Margolis EB, Wang HL, Harvey BK, Morales M (2010). Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons. J Neurosci 30: 218-229.
19. Domingos AI, Vaynshteyn J, Voss HU, Ren X, Gradinaru V, Zang F et al (2011). Leptin regulates the reward value of nutrient. Nat Neurosci 14: 1562-1568.
20. Fallon JH, Koziell DA, Moore RY (1978). Catecholamine innervation of the basal forebrain. II. Amygdala, suprarhinal cortex and entorhinal cortex. J Comp Neurol 180: 509-532.
21. Fallon JH, Moore RY (1978). Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J Comp Neurol 180: 545-580.
22. Garcia J, Kimeldorf DJ, Koelling RA (1955). Conditioned aversion to saccharin resulting from exposure to gamma radiation. Science 122: 157-158.
23. Gebre-Medhin S, Mulder H, Pekny M, Westermark G, Tornell J, Westermark P et al (1998). Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). Biochem Biophys Res Commun 250: 271-277.
24. Grabler V, Lutz TA (2004). Chronic infusion of the amylin antagonist AC 187 increases feeding in Zucker fa/fa rats but not in lean controls. Physiol Behav 81: 481-488.
25. Grill HJ (2006). Distributed neural control of energy balance: contributions from hindbrain and hypothalamus. Obesity 14(Suppl 5): 216S-221S.
26. Grill HJ, Kaplan JM (2002). The neuroanatomical axis for control of energy balance. Front Neuroendocrinol 23: 2-40.
27. Hayes MR, Mietlicki-Baase EG, Kanoski SE, De Jonghe BC (2014). Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose. Annu Rev Nutr 34: 3.1-3.24.
28. Heien ML, Johnson MA, Wightman RM (2004). Resolving neurotransmitters detected by fast-scan cyclic voltammetry. Anal Chem 76: 5697-5704.
29. Ikemoto S (2010). Brain reward circuitry beyond the mesolimbic dopamine system: a neurobiological theory. Neurosci Biobehav Rev 35: 129-150.
30. Johnson KH, O'Brien TD, Hayden DW, Jordan K, Ghobrial HK, Mahoney WC et al (1988). Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques. Am J Pathol 130: 1-8.
31. Kahn SE, D'Alessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky GJ Jr et al (1990). Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes 39: 634-638.
32. Kanoski SE, Rupprecht LE, Fortin SM, De Jonghe BC, Hayes MR (2012). The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide. Neuropharmacology 62: 1916-1927.
33. Krugel U, Schraft T, Kittner H, Kiess W, Illes P (2003). Basal and feeding-evoked dopamine release in the rat nucleus accumbens is depressed by leptin. Eur J Pharmacol 482: 185-187.
34. Lu XY, Ghasemzadeh MB, Kalivas PW (1998). Expression of D1 receptor, D2 receptor, substance P and enkephalin messenger RNAs in the neurons projecting from the nucleus accumbens. Neuroscience 82: 767-780.
35. Lucas F, Sclafani A (1996). Capsaicin attenuates feeding suppression but not reinforcement by intestinal nutrients. Am J Physiol 270: R1059-R1064.
36. Lutz TA (2005). Pancreatic amylin as a centrally acting satiating hormone. Curr Drug Targets 6: 181-189.
37. Lutz TA (2013). The interaction of amylin with other hormones in the control of eating. Diabetes Obes Metab 15: 99-111.
38. Lutz TA, Del Prete E, Scharrer E (1994). Reduction of food intake in rats by intraperitoneal injection of low doses of amylin. Physiol Behav 55: 891-895.
39. Lutz TA, Del Prete E, Scharrer E (1995a). Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin. Peptides 16: 457-462.
40. Lutz TA, Geary N, Szabady MM, Del Prete E, Scharrer E (1995b). Amylin decreases meal size in rats. Physiol Behav 58: 1197-1202.
41. Lutz TA, Senn M, Althaus J, Del Prete E, Ehrensperger F, Scharrer E (1998). Lesion of the area postrema/nucleus of the solitary tract (AP/NTS) attenuates the anorectic effects of amylin and calcitonin gene-related peptide (CGRP) in rats. Peptides 19: 309-317.
42. Lutz TA, Tschudy S, Rushing PA, Scharrer E (2000). Amylin receptors mediate the anorectic action of salmon calcitonin (sCT). Peptides 21: 233-238.
43. McCutcheon JE, Beeler JA, Roitman MF (2012). Sucrose-predictive cues evoke greater phasic dopamine release than saccharinpredictive cues. Synapse 66: 346-351.
44. Mietlicki-Baase EG, Hayes MR (2014). Amylin activates distributed CNS nuclei to control energy balance. Physiol Behav; doi:10.1016.j.physbeh.2014.01.013 (epub ahead of print 28 January 2014).
45. Mietlicki-Baase EG, Ortinski PI, Rupprecht LE, Olivos DR, Alhadeff AL, Pierce RC et al (2013a). The food intake-suppressive effects of glucagon-like peptide-1 receptor signaling in the ventral tegmental area are mediated by AMPA/kainate receptors. Am J Physiol Endocrinol Metab 305: E1367-E1374.
46. Mietlicki-Baase EG, Rupprecht LE, Olivos DR, Zimmer DJ, Alter MD, Pierce RC et al (2013b). Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake. Neuropsychopharmacology 38: 1685-1697.
47. Mogenson GJ, Wu M (1982). Electrophysiological and behavioral evidence of interaction of dopaminergic and gustatory afferents in the amygdala. Brain Res Bull 8: 685-691.
48. Mollet A, Gilg S, Riediger T, Lutz TA (2004). Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats. Physiol Behav 81: 149-155.
49. Narayanan NS, Guarnieri DJ, DiLeone RJ (2010). Metabolic hormones, dopamine circuits, and feeding. Front Neuroendocrinol 31: 104-112.
50. Olsson M, Herrington MK, Reidelberger RD, Permert J, Gebre-Medhin S, Arnelo U (2012). Food intake and meal pattern in IAPP knockout mice with and without infusion of exogenous IAPP. Scand J Gastroenterol 47: 191-196.
51. Paxinos G, Chai SY, Christopoulos G, Huang XF, Toga AW, Wang HQ et al (2004). In vitro autoradiographic localization of calcitonin and amylin binding sites in monkey brain. J Chem Neuroanat 27: 217-236.
52. Paxinos G, Watson C (2006). The Rat Brain in Stereotaxic Coordinates. 6th edn, Elsevier Academic Press: Burlington, MA.
53. Phillips PE, Johns JM, Lubin DA, Budygin EA, Gainetdinov RR, Lieberman JA et al (2003). Presynaptic dopaminergic function is largely unaltered in mesolimbic and mesostriatal terminals of adult rats that were prenatally exposed to cocaine. Brain Res 961: 63-72.
54. Roitman MF, Stuber GD, Phillips PE, Wightman RM, Carelli RM (2004). Dopamine operates as a subsecond modulator of food seeking. J Neurosci 24: 1265-1271.
55. Roth JD, Maier H, Chen S, Roland BL (2009). Implications of amylin receptor agonism: integrated neurohormonal mechanisms and therapeutic applications. Arch Neurol 66: 306-310.
56. Rushing PA, Hagan MM, Seeley RJ, Lutz TA, D'Alessio DA, Air EL et al (2001). Inhibition of central amylin signaling increases food intake and body adiposity in rats. Endocrinology 142: 5035.
57. Rushing PA, Hagan MM, Seeley RJ, Lutz TA, Woods SC (2000). Amylin: a novel action in the brain to reduce body weight. Endocrinology 141: 850-853.
58. Sadry SA, Drucker DJ (2013). Emerging combinatorial hormone therapies for the treatment of obesity and T2DM. Nat Rev Endocrinol 9: 425-433.
59. Scatton B, Simon H, Le Moal M, Bischoff S (1980). Origin of dopaminergic innervation of the rat hippocampal formation. Neurosci Lett 18: 125-131.
60. Scherbaum WA (1998). The role of amylin in the physiology of glycemic control. Exp Clin Endocrinol Diabetes 106: 97-102.
61. Schmidt HD, Pierce RC (2006). Cooperative activation of D1-like and D2-like dopamine receptors in the nucleus accumbens shell is required for the reinstatement of cocaine-seeking behavior in the rat. Neuroscience 142: 451-461.
62. Sexton PM, Paxinos G, Kenney MA, Wookey PJ, Beaumont K (1994). In vitro autoradiographic localization of amylin binding sites in rat brain. Neuroscience 62: 553-567.
63. Sinkala E, McCutcheon JE, Schuck MJ, Schmidt E, Roitman MF, Eddington DT (2012). Electrode calibration with a microfluidic flow cell for fast-scan cyclic voltammetry. Lab Chip 12: 2403-2408.
64. Skibicka KP, Shirazi RH, Rabasa-Papio C, Alvarez-Crespo M, Neuber C, Vogel H et al (2013). Divergent circuitry underlying food reward and intake effects of ghrelin: dopaminergic VTAaccumbens projection mediates ghrelin's effect on food reward but not food intake. Neuropharmacology 73: 274-283.
65. Smith SR, Blundell JE, Burns C, Ellero C, Schroeder BE, Kesty NC et al (2007). Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study. Am J Physiol Endocrinol Metab 293: E620-E627.
66. Spector AC, Breslin P, Grill HJ (1988). Taste reactivity as a dependent measure of the rapid formation of conditioned taste aversion: a tool for the neural analysis of taste-visceral associations. Behav Neurosci 102: 942-952.
67. Swanson CJ, Heath S, Stratford TR, Kelley AE (1997). Differential behavioral responses to dopaminergic stimulation of nucleus accumbens subregions in the rat. Pharmacol Biochem Behav 58: 933-945.
68. Vucetic Z, Reyes TM (2010). Central dopaminergic circuitry controlling food intake and reward: implications for the regulation of obesity. Wiley Interdiscip Rev Syst Biol Med 2: 577-593.
69. Wanat MJ, Kuhnen CM, Phillips PE (2010). Delays conferred by escalating costs modulate dopamine release to rewards but not their predictors. J Neurosci 30: 12020-12027.
70. Young A (2005). Receptor pharmacology. Adv Pharmacol 52: 47-65.